Stereotactic body radiotherapy for early glottic cancers: Is this “The Way”?
Clinical and Translational Radiation Oncology · 2025-07 · 53 · 100962
DOI: 10.1016/j.ctro.2025.100962 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical and Translational Radiation Oncology, 2025-07. Verfasst von Jennifer Le Guévelou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratoire de traitement de l'image et du signal, University of Rennes, France. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In the past decades, several options have been designed in order to preserve vocal function in patients with early glottic cancer, such as transoral laser microsurgery, new surgical strategies such as partial laryngectomy and radiation therapy (RT). With the development of new radiation techniques enabling a more accurate delivery of radiation dose, and the possibility to deliver high dose per fraction while sparing adjacent organs-at-risks (OARs), stereotactic body radiotherapy (SBRT) is being increasingly tested in this disease setting. We aimed to shed light on this appealing strategy, as well as to underline both optimal target population and specific technical considerations.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratoire de traitement de l'image et du signal, University of Rennes, France.
- Department of Research, Centre Eugène Marquis, Rennes, France.
- Department of Radiotherapy, Centre François Baclesse, Caen, France.
- Department of Radiotherapy, Institut Gustave Roussy, Université Paris Saclay, Villejuif, France.
- Department of Radiotherapy, Institut inter-régional de Cancérologie (ILC) - Centre jean Bernard, Centre de cancérologie de la Sarthe (CCS) - Clinique Victor Hugo, Le Mans, France.
- Department of Radiotherapy, Centre Eugène Marquis, Rennes, France.
Zitieren
APA
Le Guévelou, J., Larnaudie, A., Blanchard, P., Pointreau, Y., & Castelli, J. (2025). Stereotactic body radiotherapy for early glottic cancers: Is this “The Way”?. Clinical and Translational Radiation Oncology, 53, 100962. https://doi.org/10.1016/j.ctro.2025.100962
Vancouver
Le Guévelou J, Larnaudie A, Blanchard P, Pointreau Y, Castelli J. Stereotactic body radiotherapy for early glottic cancers: Is this “The Way”?. Clinical and Translational Radiation Oncology. 2025;53:100962. doi:10.1016/j.ctro.2025.100962
BibTeX
@article{LeGuvelou2025,
author = {Le Guévelou, Jennifer and Larnaudie, Audrey and Blanchard, Pierre and Pointreau, Yoann and Castelli, Joël},
title = {Stereotactic body radiotherapy for early glottic cancers: Is this “The Way”?},
journal = {Clinical and Translational Radiation Oncology},
year = {2025},
volume = {53},
pages = {100962},
doi = {10.1016/j.ctro.2025.100962}
}
EUVIMED